LIVMONIPLIMAB
UNII 42SH7JCD82

Substance Identification & Data

This profile provides standardized clinical and technical data for Livmoniplimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 42SH7JCD82.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2412004-88-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

42SH7JCD82

CAS Registry Number

2412004-88-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIVMONIPLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C165684

National Cancer Institute reference terminology for clinical and research data.

INN ID

11741

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-234

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Livmoniplimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIVMONIPLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (234-PROLINE), ANTI-(HUMAN PROTEIN GARP-TRANSFORMING GROWTH FACTOR .BETA.1 COMPLEX) (HUMAN MONOCLONAL ABBV-151 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ABBV-151 .KAPPA.-CHAIN, DIMER

LIVMONIPLIMAB [INN]

LIVMONIPLIMAB [USAN]

LIVMONIPLIMAB [WHO-DD]